- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07267858
Clinical Pilates Programme on People With COPD Gold A: a Rehabilitation Nursing Approach. (COPD_CPilates)
Effect of a Clinical Pilates Programme on Individuals With Gold A COPD on Lung Function, Motor Performance, Chest Mobility, Sleep and Physical Activity, and Health-related Quality of Life: an Interactive Approach Between Rehabilitation Nursing and Sports Sciences.
The main objective of this study is to evaluate the effects of a Clinical Pilates-based exercise programme on chest mobility, lung function, motor performance, physical activity levels, sleep quality and Health-Related Quality of Life (HRQoL) in individuals with Gold A COPD. Based on our research question, 'What is the effect of a Clinical Pilates programme on thoracic mobility, pulmonary function, motor performance, physical activity levels, sleep quality, and HRQoL in people with Gold A COPD?', we propose the following research hypotheses:
H1: The Clinical Pilates programme contributed to improved thoracic mobility in people with Gold A COPD.
H2: The Clinical Pilates programme contributed to improved lung function in people with Gold A COPD.
H3: The Clinical Pilates programme positively influences the motor performance of people with Gold A COPD.
H4: The Clinical Pilates programme positively influences the physical activity levels of people with COPD Gold A.
H5: The Clinical Pilates programme positively influences the sleep quality of people with COPD Gold A.
H6: The Clinical Pilates programme contributes to improving the HRQoL levels of people with COPD Gold A.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Guimarães, Portugal, 4800
- Unidade de Cuidados na Comunidade de Guimarães
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Anyone diagnosed with COPD at GOLD stage A, duly identified in SClínico, registered with the USF and residing in the geographical area covered by the Guimarães UCC, whose participation is validated by their family doctor. Inclusion in the study implies participation in at least 60% of the programme sessions, namely 10.
Exclusion Criteria:
- People with a history of exacerbation of the disease less than 4 weeks ago, as the guidelines of the European Respiratory Society and the American Thoracic Society (2017) make a conditional recommendation on pulmonary rehabilitation after exacerbation and recommend waiting at least 3 weeks, severe osteoarticular limitation that prevents physical exercise, psychiatric illness or severe cognitive dysfunction, unstable comorbidities such as unstable ischaemic disease or decompensated heart failure, and exercise-induced hypoxemia refractory to oxygen administration.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Clinical Pilates Group (CPG)
Group of individuals with ongoing rehabilitation nursing consultations who participate in the CP programme consisting of 16 sessions of 60 minutes each.
|
8-week programme with face-to-face sessions twice a week, lasting approximately 60 minutes per session, using equipment such as soft balls and elastic bands.
|
|
No Intervention: Control Group (CG)
Group that only underwent follow-up rehabilitation nursing consultations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing, on thoracic mobility in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
Chirometric tests of the Thorax (Lanza et al., 2013).
|
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
|
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on pulmonary function in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
Peak expiratory flow - Peak Flow (Miler et al., 2005).
|
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
|
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on motor performance in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
One-minute sit-to-stand test (Vaidya et al., 2016) and modified Borg scale (Borg, 1982).
|
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
|
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on physical activity levels in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
Actigraph® GT3X+ accelerometer. The brand protocol requires wearing the device for a period of 4 days, including 2 days at the weekend. The device will be programmed for 6 hours on the first day of assessment and recordings will be made every 15 seconds. A record sheet will be provided to indicate the times when the accelerometer is put on and taken off. The device is placed on the non-dominant wrist and daily recording of at least 600 minutes (10 hours) is mandatory. |
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
|
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on sleep quality in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
The brand protocol requires wearing the device for a period of 4 days, including 2 days at the weekend. The device will be programmed for 6 hours on the first day of assessment and recordings will be made every 15 seconds. A record sheet will be provided to indicate the times when the accelerometer is put on and taken off. The device is placed on the non-dominant wrist and daily recording of at least 600 minutes (10 hours) is mandatory. |
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
|
Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on Health-related quality of life (HRQoL) in people with COPD Gold A.
Time Frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
EQ-5D-5L (Ferreira et al., 2023). Likert scale (1 to 5) self-assessment that considers 5 domains:
|
Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 142/2024-CAF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD (Chronic Obstructive Pulmonary Disease)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Morair Medtech, LLCRecruitingEmphysema | COPD | Emphysema or COPD | COPD (Chronic Obstructive Pulmonary Disease) | Emphysema, PulmonaryAustria, Germany, Netherlands
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Barron Associates, Inc.National Heart, Lung, and Blood Institute (NHLBI); University of VirginiaNot yet recruitingCOPD | COPD - Chronic Obstructive Pulmonary DiseaseUnited States
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
Clinical Trials on Clinical Pilates for people with COPD Gold A.
-
University of Colorado, DenverNot yet recruitingCOPD (Chronic Obstructive Pulmonary Disease)United States
-
Rennes University HospitalINRIA, Hybrid team; Ecole Centrale Nantes, laboratoire Ambiances, Architectures...CompletedAlzheimer or Mild Cognitive ImpairmentFrance
-
McGill UniversityFondation Québécoise en Santé RespiratoireCompletedPulmonary Disease, Chronic ObstructiveCanada
-
Khon Kaen UniversityThailand Research FundUnknownChronic Obstructive Pulmonary DiseaseThailand
-
Second Affiliated Hospital of Nanchang UniversityActive, not recruitingMild Depressive Disorder Comorbid With Anxiety DisorderChina
-
Hospital Universitari Vall d'Hebron Research InstituteAssistance Publique - Hôpitaux de Paris; Charite University, Berlin, Germany; UMC Utrecht and other collaboratorsActive, not recruitingSickle Cell DiseaseNetherlands, Italy, Spain
-
Luleå Tekniska UniversitetCompleted
-
Jan JakobssonUniversity of California, IrvineTerminated
-
Prince Sattam Bin Abdulaziz UniversityActive, not recruitingBone Augmentation | Tooth Extraction Status NosSaudi Arabia
-
Istanbul Medipol University HospitalCompletedDental Restoration FailuresTurkey